But new DNA evidence shows that many of those stories are wrong, researchers reported Thursday in the journal Current Biology. A team of U.S. and European researchers conducted genomic testing on ...
Myriad Genetics, Inc., (NASDAQ: MYGN), a leader in genetic testing and precision medicine, continues to empower parents with increased access to prenatal testing. SneakPeek, the #1 OBGYN-recommended ...